company background image
AEZS

Aeterna Zentaris TSX:AEZS Stock Report

Last Price

CA$5.02

Market Cap

CA$24.4m

7D

2.7%

1Y

-67.1%

Updated

26 Nov, 2022

Data

Company Financials +
AEZS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

AEZS Stock Overview

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests.

Aeterna Zentaris Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aeterna Zentaris
Historical stock prices
Current Share PriceCA$5.02
52 Week HighCA$16.50
52 Week LowCA$4.66
Beta1.7
1 Month Change-14.04%
3 Month Change-24.28%
1 Year Change-67.08%
3 Year Change-83.13%
5 Year Change-91.97%
Change since IPO-99.99%

Recent News & Updates

Recent updates

We're Hopeful That Aeterna Zentaris (TSE:AEZS) Will Use Its Cash Wisely

May 10
We're Hopeful That Aeterna Zentaris (TSE:AEZS) Will Use Its Cash Wisely

We're Interested To See How Aeterna Zentaris (TSE:AEZS) Uses Its Cash Hoard To Grow

Nov 12
We're Interested To See How Aeterna Zentaris (TSE:AEZS) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Aeterna Zentaris' (TSE:AEZS) Cash Burn Situation

Jul 15
Here's Why We're Not At All Concerned With Aeterna Zentaris' (TSE:AEZS) Cash Burn Situation

Companies Like Aeterna Zentaris (TSE:AEZS) Can Afford To Invest In Growth

Mar 29
Companies Like Aeterna Zentaris (TSE:AEZS) Can Afford To Invest In Growth

Reflecting on Aeterna Zentaris' (TSE:AEZS) Share Price Returns Over The Last Five Years

Feb 04
Reflecting on Aeterna Zentaris' (TSE:AEZS) Share Price Returns Over The Last Five Years

Shareholder Returns

AEZSCA BiotechsCA Market
7D2.7%-0.3%2.1%
1Y-67.1%-15.2%-1.4%

Return vs Industry: AEZS underperformed the Canadian Biotechs industry which returned -15.7% over the past year.

Return vs Market: AEZS underperformed the Canadian Market which returned -3.7% over the past year.

Price Volatility

Is AEZS's price volatile compared to industry and market?
AEZS volatility
AEZS Average Weekly Movement7.1%
Biotechs Industry Average Movement11.0%
Market Average Movement10.0%
10% most volatile stocks in CA Market18.0%
10% least volatile stocks in CA Market4.1%

Stable Share Price: AEZS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: AEZS's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199012Klaus Paulinihttps://www.zentaris.com

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name.

Aeterna Zentaris Inc. Fundamentals Summary

How do Aeterna Zentaris's earnings and revenue compare to its market cap?
AEZS fundamental statistics
Market CapCA$24.38m
Earnings (TTM)-CA$17.62m
Revenue (TTM)CA$5.50m

4.4x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AEZS income statement (TTM)
RevenueUS$4.11m
Cost of RevenueUS$124.00k
Gross ProfitUS$3.99m
Other ExpensesUS$17.16m
Earnings-US$13.17m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.71
Gross Margin96.98%
Net Profit Margin-320.36%
Debt/Equity Ratio0%

How did AEZS perform over the long term?

See historical performance and comparison